Prosecution Insights
Last updated: July 17, 2026
Application No. 18/280,396

TRICYCLIC PESTICIDAL COMPOUNDS

Non-Final OA §102
Filed
Sep 05, 2023
Priority
Mar 09, 2021 — IN 202121009819 +2 more
Examiner
JAVANMARD, SAHAR
Art Unit
1622
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
BASF SE
OA Round
1 (Non-Final)
65%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
484 granted / 742 resolved
+5.2% vs TC avg
Strong +35% interview lift
Without
With
+34.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
46 currently pending
Career history
782
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
75.5%
+35.5% vs TC avg
§102
8.8%
-31.2% vs TC avg
§112
8.3%
-31.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 742 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Claims This Office Action is in response to Applicant's Restriction Requirement remarks filed on January 22, 2026. Applicant's election of species of compound 1.3 of the restriction requirement in the reply is acknowledged. Examiner searched Formula I in its entirety. The species requirement is hereby withdrawn. Claim(s) 1-9 and 11-16 are examined herein insofar as they read on the elected invention. Objection Claim 1, the definition of R2, after HO there is a “.”, should be a “,”. Corrective action is required. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-7 are rejected under 35 U.S.C. 102 (a)(1) as being anticipated by Yokomori (JP 01193252). Yokomori teaches imidazole compounds of formula I as defined below and specific compound as having potent antiulcer activity. PNG media_image1.png 678 828 media_image1.png Greyscale Based on the foregoing reasons, the instant claims are deemed anticipated over the cited art. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-9 and 11-16 are rejected under 35 U.S.C. 102 (a)(2) as being anticipated by Von Deyn (WO 2020/083662) of record. Von Deyn teaches compounds of formula I as an agrochemical pesticide (claims 1-8). The scope of formula I overlaps with formula I of the instant claims. Von Deyn teaches a pesticidal mixture comprising a compound of formula (I) and another agrochemically active ingredient (claim 10). Von Deyn teaches the pesticidal mixture and a liquid or solid carrier (claim 11). Von Deyn teaches methods for controlling invertebrate pests, infestation, or infection by invertebrate pests, comprising contacting the pests, their food supply, habitat, breeding grounds or their locus with a compound of formula (I) (claim 12). Von Deyn teaches a seed comprising a compound of formula (I) as defined in any of claims 1 to 8, or a pesticidal mixture as defined in claim 10 in an amount of from 0.1 g to 10 kg per 100 kg of seeds (claim 13). Based on the foregoing reasons, the instant claims are deemed anticipated over the cited art. Conclusion Claims 1-9 and 11-16 are not allowed. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Sahar Javanmard whose telephone number is (571)270-3280. The examiner can normally be reached on Monday-Friday, 9:00-5:00 EST. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, James Alstrum-Acevedo can be reached on 571-272-5548. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. /SAHAR JAVANMARD/Primary Examiner, Art Unit 1622
Read full office action

Prosecution Timeline

Sep 05, 2023
Application Filed
May 22, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12673956
OXADIAZOLYL DIHYDROPYRANO[2,3-b]PYRIDINE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS
2y 11m to grant Granted Jul 07, 2026
Patent 12667563
PROPHYLACTIC OR THERAPEUTIC AGENT FOR PORPHYRIA
3y 6m to grant Granted Jun 30, 2026
Patent 12661352
COMBINATION THERAPY WITH CLK/DYRK INHIBITORS AND BCL2 INHIBITORS TO TREAT LEUKEMIA
10m to grant Granted Jun 23, 2026
Patent 12653819
FORMULATIONS AND TREATMENT METHODS
4y 3m to grant Granted Jun 16, 2026
Patent 12653855
OPTIMIZING VOLATILE ENTOURAGES IN DRY FLOWERING PLANT MIXTURES
3y 1m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
99%
With Interview (+34.8%)
2y 10m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 742 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month